Covaxin approval is a giant leap for innovation: Bharat Biotech MD
By MYBRANDBOOK
The approval of COVAXIN for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and Managing Director of Bharat Biotech, said.
DCGI-Central Standards Control Organization gave a green signal for the emergency use of its Covid-19 vaccine. Expressing his delight on the approval, the CMD of vaccine maker said, "It is a proud moment for the nation and a great milestone in India's scientific capability. While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the most. COVAXIN has generated excellent safety data with robust immune responses to multiple viral proteins that persist.
"The development of COVAXIN was based on a public-private partnership between ICMR, NIV and Bharat Biotech. We thank Director-General ICMR Balram Bhargava for his leadership in this project," he said.
The Subject Expert Committee of Central Drugs Standards Control Organization made the recommendations for the Drugs Controller General of India's final decision.
Developed in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV), COVAXIN is indigenous, inactivated vaccine developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) bio-containment facility, one of its kind in the world.
The evaluation of COVAXIN has resulted in several unique product characteristics, including long term persistence of immune responses to multiple viral proteins instead of only the spike protein. It demonstrated broad-spectrum neutralizing capability with heterologous SARS-CoV2 strains, thus potentially reducing or eliminating escape mutants. It critical characteristic is the demonstrated safety profile, which is significantly lower than several other vaccines with published data.
Thus far, the product development and clinical trial data have generated five publications, 4 of which have been accepted and published soon. The publication of phase II trial data is undergoing the peer review process. As a part of our regulatory guidelines, all data has been submitted to the DCGI and CDSCO.
Bharat Biotech has 140 global patents and a product portfolio of more than 16 vaccines, four bio-therapeutics, registrations in more than 116 countries and WHO Pre-qualifications.
The company has delivered over 4 billion doses of vaccines worldwide and continues to lead innovation. It has developed vaccines for influenza H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika and the world's first tetanus-toxoid conjugated vaccine for Typhoid.
BHIM to join e-commerce, competing with PhonePe and Google Pay
The government-supported payment software BHIM is getting ready to join t...
The latest version of X helps prevent deepfakes on social medi
To combat deepfakes and shallowfakes, Elon Musk revealed a new update t...
India and Namibia collaborate on a payment system similar to U
Once operational, the platform will enable digital transactions in Namibia,...
Sebi issues show-cause notices to six Adani group firms
Sebi issued show-cause notices to six Adani Group firms, including Adani ...
AMARA RAJA POWER SYSTEMS LTD.
QUICK HEAL TECHNOLOGIES PVT. Ltd.
TAC SECURITY SOLUTIONS
LENOVO GROUP LTD.
Technology Icons Of India 2023: Roshni Nadar Malhotra
Roshni Nadar Malhotra is an Indian billionaire businesswoman and the c...
Technology Icons Of India 2023: Rishad Premji
Rishad Premji is the son of the Wipro head Azim Premji and was named a...
Technology Icons Of India 2023: Sunil Vachani
Sunil Vachani is the founder and chairman of India-listed Dixon Techno...
NIC bridging the digital divide and supporting government in eGovernance
The National Informatics Centre (NIC) is an Indian government departme...
PGCIL transforming India with its wide power transmission network
Engaged in power transmission, POWERGRID or PGCIL is a stated owned In...
New defence PSUs will help India become self-reliant
MIL, India’s biggest manufacturer and market leader is engaged in Pr...
B D SOFTWARE
BD Software is the distributor of IT security solutions in India. The ...
FORTUNE MARKETING PVT. LTD.
Delhi based Fortune Marketing, An ISO 9001:2008 company, distributes ...
RAH INFOTECH
RAH Infotech is India’s fastest growing technology value added dist...